Diabetes and CAD

NEW YORK, July 25 (Praxis Press) Risk factors such as smoking and hypertension explain much of the excess risk for coronary artery disease (CAD) produced by type 2 diabetes, but nontraditional factors such as albumin, fibrinogen, factor VIII, and von Willebrand factor may also increase CAD risk. To examine this relationship, Saito and colleagues performed a prospective cohort study of 1,676 middle-aged persons who had diabetes but no history of prevalent CAD. They recorded multiple risk factors

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NEW YORK, July 25 (Praxis Press) Risk factors such as smoking and hypertension explain much of the excess risk for coronary artery disease (CAD) produced by type 2 diabetes, but nontraditional factors such as albumin, fibrinogen, factor VIII, and von Willebrand factor may also increase CAD risk. To examine this relationship, Saito and colleagues performed a prospective cohort study of 1,676 middle-aged persons who had diabetes but no history of prevalent CAD. They recorded multiple risk factors at baseline and followed the patients from 1987 through 1995. They found that 186 participants developed incident coronary artery disease events during follow-up and after adjusting for traditional CAD risk factors, only levels of albumin, fibrinogen, von Willebrand factor, factor VIII activity, and leukocyte count remained independently associated with coronary artery disease. Non-traditional factors such as levels of albumin, fibrinogen, may increase the risk of CAD in patients with diabetes.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform